Clostridium Novyi-NT
Phase 1Biologic
Clostridium Novyi-NT is one of 5 biologic programs targeting Intratumoral Injection. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Intratumoral Injection
#DrugCompanyPhaseTrials
1Keytruda
Merck & Co.Phase 1
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 1
OH2
BBinhui Biopharmaceutical Co., Ltd.
Phase 1
IV Cisplatin
UUniversitair Ziekenhuis Brussel
Phase 2
Clostridium Novyi-NT
MM.D. Anderson Cancer Center
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Clostridium Novyi-NT. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 1[1]
- Company
- MM.D. Anderson Cancer Center